documents: FDA-2025-N-6895-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2025-N-6895-0001 | FDA | FDA-2025-N-6895 | Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List | Notice | Request for Comments | 2026-04-16T04:00:00Z | 2026 | 4 | 2026-04-16T04:00:00Z | 2026-07-23T03:59:59Z | 2026-05-15T09:00:20Z | 2026-07361 | 1 | 0 | 09000064b92865ab |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref